What's new

Human medicines European public assessment report (EPAR): Evusheld, tixagevimab,cilgavimab, Date of authorisation: 25/03/2022, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Evusheld, tixagevimab,cilgavimab, Date of authorisation: 25/03/2022, Revision: 9, Status: Authorised

Mar 12, 2025 - 16:56
 0
Human medicines European public assessment report (EPAR): Evusheld, tixagevimab,cilgavimab, Date of authorisation: 25/03/2022, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Evusheld, tixagevimab,cilgavimab, Date of authorisation: 25/03/2022, Revision: 9, Status: Authorised
Read More

Tags:

Previous Article

IRIS guide for applicants - How to create and submit scientific applications, fo...

Next Article

UVM Health expands child care for employees

Related Posts

List of European Union reference dates (EURD) and frequ...

Feb 9, 2025  0

Vitrolife IVF media - Procedural steps and scientific i...

Mar 5, 2025  0

PRIME: priority medicines

PRIME: priority medicines

Feb 9, 2025  0